Retatrutide 20mg

Triple receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously. Retatrutide represents the next generation of metabolic research compounds, engineered to engage three distinct hormonal axes involved in energy expenditure, glucose regulation, and adipose tissue reduction.

Currently among the most studied peptides in advanced metabolic research, with clinical data suggesting superior efficacy over dual-agonist compounds in body composition and glycaemic outcomes.

$359 20mg / vial SKU: ZL-MET-003

For research use only. Not intended for human consumption. All batches independently tested with full Certificate of Analysis documentation.